Bidda Rolin
Novo Nordisk (Denmark)(DK)
Publications by Year
Research Areas
Pancreatic function and diabetes, Diabetes Treatment and Management, Diabetes Management and Research, Metabolism, Diabetes, and Cancer, Diabetes and associated disorders
Most-Cited Works
- → The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE−/− and LDLr−/− Mice by a Mechanism That Includes Inflammatory Pathways(2018)459 cited
- → Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes.(1998)312 cited
- → The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases β-cell mass in diabetic mice(2002)280 cited
- → Liraglutide, a Long-Acting Glucagon-Like Peptide-1 Analog, Reduces Body Weight and Food Intake in Obese Candy-Fed Rats, Whereas a Dipeptidyl Peptidase-IV Inhibitor, Vildagliptin, Does Not(2006)209 cited
- → GLP‐1 derivative liraglutide in rats with β‐cell deficiencies: influence of metabolic state on β‐cell mass dynamics(2003)200 cited
- → Use of the Gottingen Minipig as a Model of Diabetes, with Special Focus on Type 1 Diabetes Research(2004)193 cited
- → Immunoneutralization of endogenous glucagon with monoclonal glucagon antibody normalizes hyperglycaemia in moderately streptozotocin-diabetic rats(1994)137 cited
- → Mild streptozotocin diabetes in the Göttingen minipig. A novel model of moderate insulin deficiency and diabetes(2002)100 cited
- → NN2211: a long-acting glucagon-like peptide-1 derivative with anti-diabetic effects in glucose-intolerant pigs(2002)77 cited
- → Chamber-Dependent Expression of Brain Natriuretic Peptide and Its mRNA in Normal and Diabetic Pig Heart(2002)63 cited